2007
DOI: 10.1007/s10620-006-9404-x
|View full text |Cite
|
Sign up to set email alerts
|

Gut Toxicity During Hemopoietic Stem Cell Transplantation May Predict Acute Graft-Versus-Host Disease Severity in Patients

Abstract: Graft-versus-host disease (GVHD) is the primary complication of allogeneic, hemopoietic, stem cell transplantation (HSCT). Murine models suggest that gut toxicity, induced by the intensive chemotherapy preceding hematopoietic stem cell infusion, aggravates systemic GVHD. In HSCT patients gut toxicity correlates with chemotherapy intensity. The present study investigates acute GVHD severity and intestinal toxicity in patients undergoing allogeneic HSCT. In 38 patients intestinal permeability was assessed before… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

3
45
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 48 publications
(48 citation statements)
references
References 20 publications
3
45
0
Order By: Relevance
“…Then, inflammatory cellderived IL-1β might cooperate with multiple innate and adaptive effector pathways (39) to propagate an inflammatory reaction. In humans, IL-1β up-regulation following DNA damage is observed in cancer patients with mucositis (28), a severe pathologic condition affecting most patients treated with standard chemotherapy or radiation therapy (28,40). Anti-IL-1β treatment may thus ameliorate mucositis as well as multiple disorders associated with barrier permeability, including burn injuries (33), head and neck trauma (41), cardiogenic shock (42), alcoholic intoxication (43), and graft-vs.-host disease (40).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Then, inflammatory cellderived IL-1β might cooperate with multiple innate and adaptive effector pathways (39) to propagate an inflammatory reaction. In humans, IL-1β up-regulation following DNA damage is observed in cancer patients with mucositis (28), a severe pathologic condition affecting most patients treated with standard chemotherapy or radiation therapy (28,40). Anti-IL-1β treatment may thus ameliorate mucositis as well as multiple disorders associated with barrier permeability, including burn injuries (33), head and neck trauma (41), cardiogenic shock (42), alcoholic intoxication (43), and graft-vs.-host disease (40).…”
Section: Discussionmentioning
confidence: 99%
“…In humans, IL-1β up-regulation following DNA damage is observed in cancer patients with mucositis (28), a severe pathologic condition affecting most patients treated with standard chemotherapy or radiation therapy (28,40). Anti-IL-1β treatment may thus ameliorate mucositis as well as multiple disorders associated with barrier permeability, including burn injuries (33), head and neck trauma (41), cardiogenic shock (42), alcoholic intoxication (43), and graft-vs.-host disease (40). Furthermore, preventive anti-IL-1β treatment may obviate the common need for chemoradiation therapy suspension as a result of mucositis and improve patients' quality of life during treatment.…”
Section: Discussionmentioning
confidence: 99%
“…Nonetheless, persistent microbial translocation during HIV infection owing to increased gut permeability could exercise unfavorable effects on the disease course through multiple mechanisms (12). The effects of microbial translocation on the nervous system are unappreciated to date in diseases-such as inflammatory and altered permeability bowel diseases (64), graft-versus host disease (65), and lymphangiectasia (66)-in which it is posited to be a pathogenic factor.…”
Section: Discussionmentioning
confidence: 99%
“…6 However, the same mechanism is thought to have an important role for the significant increase in aGVHD in patients with higher degrees of gastrointestinal injury and mucosal permeability during HSCT. 7 It thus seems logical that it is the total amount of bacterial components that enters the systemic circulation that correlate with the risk of aGVHD, and that the amount needed to trigger aGVHD differs among patients, depending on whether other risk factors are present or not. If so, it may be that BSI or mucositis alone will suffice to trigger aGVHD in some patients, whereas in others the combination is required.…”
mentioning
confidence: 99%